Details for 2021714685

Up to date per 03.04.2026

Actions

Title / Product Name

BEHANDLUNG VON TYP 2 DIABETES MIT 2-[(4{6-((4-CYANO-2-FLUORBENZYL)OXY)PYRIDIN-2-YL}PIPERIDIN-1-YL)METHYL!-1-[(2S)-OXETAN-2-YLMETHYL)-1H-BENZIMIDAZOL-6-CARBONSÄURE ODER EINEM PHARMAZEUTISCHEN SALZ DAVON

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2021714685

EP Publication Number

4125896

E-Number

1791722

Language

PCT Number

IB21052430

Publication Date

08.02.2023 A

07.05.2025 B1

Registration Date

07.05.2025

AT Publication Date

15.05.2025

Application Date

24.03.2021

Registration Number

Priorities

27.03.2020

202063000787 P

16.12.2020

202063126113 P

11.01.2021

202163135870 P

IPC

A61K 31/4545 20060101AFI20211001BHEP

Maximum Duration of Protection

24.03.2041

Owner

Pfizer Inc.66 Hudson Boulevard East New York, NY 10001-2192US

Representative

No representatives present

Inventor

LEE, Kai Teckc/o Pfizer R&D UK Limited Ramsgate Road Sandwich Kent CT13 9NJGB

MANTHENA, Swetac/o Pfizer Inc. 445 Eastern Point Road, Bldg. 98 Groton, Connecticut 06340US

SAXENA, Aditi Raoc/o Pfizer Inc. 610 Main Street Cambridge, Massachusetts 02139US